Kentaro Suzuki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kentaro Suzuki has a total of 348 co-authors. Here are the top co-authors by number of shared publications:
Kazumi Kimura
Department of Neurology, Nippon Medical School Hospital
18 shared publicationsYasuhiro Nishiyama
Department of Neurology, Nippon Medical School, Tokyo, Japan
16 shared publicationsJunya Aoki
15 shared publicationsSeiji Okubo
Department of Cerebrovascular Medicine, NTT Medical Center Tokyo, Tokyo, Japan
14 shared publicationsTakuya Kanamaru
Department of Neurology, Nippon Medical School, Japan
12 shared publications- Satoshi Suda
Department of Neurology, Nippon Medical School, Tokyo, Japan
10 shared publications
Latest Publications
- Open Access
- 7 August 2026
- Published by Elsevier in World Neurosurgery
- Vol. 213
Functional Outcome and Procedure-related Subarachnoid Hemorrhage in Primary M2 Occlusion: Impact of Initial Thrombectomy Strategy and Procedural Factors
- 7 August 2026
- Published by Elsevier in World Neurosurgery
- Vol. 213
Open AccessFunctional Outcome and Procedure-related Subarachnoid Hemorrhage in Primary M2 Occlusion: Impact of Initial Thrombectomy Strategy and Procedural Factors
- 14 April 2026
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 47 (11) , 2752-2757
Role of Microcatheter Tip Position and Microguidewire Stiffness in Safe Neuroendovascular Navigation of Distal Vessels
Advancements in neuroendovascular devices have enabled greater access to distal, tortuous vasculature. However, this expanded capability also increases the risk of serious hemorrhagic complications during device navigation. The aim of the study is to quantify how microcatheter position and microguidewire stiffness affect tip contact force at a distal middle cerebral artery segment. A moderate tortuosity silicone model of the middle cerebral artery was used to evaluate three 0.014" Synchro SELECT microguidewires (Soft, Standard, Support) with a TrevoTrak 21 microcatheter positioned proximally in the M1 or distally in the M2 segment. Tip contact forces at the distal end of the M2 segment were recorded with a digital force gauge serving as a standardized surrogate for the distal vessel wall during motorized controlled wire advancement. From the force-distance curves, tip contact force slopes (mN/mm) and maximum tip contact forces (mN) were calculated and statistically compared across wire types and catheter positions. With distal microcatheter support, the average tip contact force slopes were 10.64 mN/mm (Soft), 10.85 mN/mm (Standard), and 15.28 mN/mm (Support) (p < 0.0001). With proximal support, the average slopes were significantly lower: 1.61 mN/mm (Soft), 3.15 mN/mm (Standard), and 3.87 mN/mm (Support) (p < 0.01). Distal microcatheter positioning consistently produced approximately 3 to 6-fold higher tip contact force slopes and higher maximum tip contact forces than proximal positioning. Microcatheter tip position and microguidewire stiffness were the primary determinants of tip contact force transmitted to distal vessel segments during neuroendovascular navigation in this model. Stiffer microguidewires exert significantly greater tip contact force, particularly when the microcatheter is positioned near the distal segment. Maintaining the microcatheter tip proximally attenuates these forces and offers a simple strategy to reduce mechanical loading of fragile distal branches during distal access procedures.
- 14 April 2026
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 47 (11) , 2752-2757
Role of Microcatheter Tip Position and Microguidewire Stiffness in Safe Neuroendovascular Navigation of Distal Vessels
Advancements in neuroendovascular devices have enabled greater access to distal, tortuous vasculature. However, this expanded capability also increases the risk of serious hemorrhagic complications during device navigation. The aim of the study is to quantify how microcatheter position and microguidewire stiffness affect tip contact force at a distal middle cerebral artery segment. A moderate tortuosity silicone model of the middle cerebral artery was used to evaluate three 0.014" Synchro SELECT microguidewires (Soft, Standard, Support) with a TrevoTrak 21 microcatheter positioned proximally in the M1 or distally in the M2 segment. Tip contact forces at the distal end of the M2 segment were recorded with a digital force gauge serving as a standardized surrogate for the distal vessel wall during motorized controlled wire advancement. From the force-distance curves, tip contact force slopes (mN/mm) and maximum tip contact forces (mN) were calculated and statistically compared across wire types and catheter positions. With distal microcatheter support, the average tip contact force slopes were 10.64 mN/mm (Soft), 10.85 mN/mm (Standard), and 15.28 mN/mm (Support) (p < 0.0001). With proximal support, the average slopes were significantly lower: 1.61 mN/mm (Soft), 3.15 mN/mm (Standard), and 3.87 mN/mm (Support) (p < 0.01). Distal microcatheter positioning consistently produced approximately 3 to 6-fold higher tip contact force slopes and higher maximum tip contact forces than proximal positioning. Microcatheter tip position and microguidewire stiffness were the primary determinants of tip contact force transmitted to distal vessel segments during neuroendovascular navigation in this model. Stiffer microguidewires exert significantly greater tip contact force, particularly when the microcatheter is positioned near the distal segment. Maintaining the microcatheter tip proximally attenuates these forces and offers a simple strategy to reduce mechanical loading of fragile distal branches during distal access procedures.
- 1 January 2026
- Published by Wolters Kluwer Health in Stroke
- Vol. 57 (1) , 27-37
Acute Carotid Stenting for Tandem Lesions in Patients Randomized to Endovascular Treatment With or Without Thrombolysis: Results From the IRIS Individual Participant Data Meta-Analysis
BACKGROUND: Equipoise persists whether patients with stroke with carotid tandem lesions undergoing endovascular treatment (EVT) should undergo acute carotid stenting, and whether intravenous thrombolysis (IVT) before EVT should influence this decision. We assessed functional and safety outcomes of acute carotid stenting in patients with carotid tandem lesions randomized to IVT plus EVT or EVT alone. METHODS: Individual participant data meta-analysis of 6 randomized clinical trials conducted in Asia, Europe, and Oceania between 2017 and 2021 investigating IVT plus EVT versus EVT alone in patients with carotid tandem lesions presenting directly to EVT-capable centers. The primary outcome was the 90-day modified Rankin Scale score, assessed with mixed-effect ordinal regression models. Safety outcomes were any intracranial hemorrhage and symptomatic intracranial hemorrhage. A secondary analysis used inverse probability of treatment weighting. Treatment effect heterogeneity between IVT plus EVT and EVT alone was assessed in a 2-step meta-analysis. RESULTS: Overall, 340 of 2267 (15%) patients had carotid tandem lesions with 113 of 329 (34%) undergoing acute carotid stenting. Stenting was associated with better 90-day functional outcomes (adjusted common odds ratio, 1.60 [95% CI, 1.03–2.47]), confirmed in inverse probability of treatment weighting analysis (adjusted common odds ratio, 1.66 [95% CI, 1.08–2.54]). Patients undergoing stenting had no statistically significant higher rates of any intracranial hemorrhage (44% versus 35%; adjusted odds ratio, 1.30 [95% CI, 0.79–2.15]) and symptomatic intracranial hemorrhage (6.3% versus 3.7%; adjusted odds ratio, 2.09 [95% CI, 0.78–5.59]). No heterogeneity in treatment effect was observed in patients randomized to IVT plus EVT (adjusted common odds ratio, 2.07 [95% CI, 1.06–4.07]) or EVT alone (1.21 [95% CI, 0.59–2.50]; P interaction=0.81). CONCLUSIONS: In this international individual participant data meta-analysis of patients with carotid tandem lesions randomized to EVT alone or IVT followed by EVT, acute carotid stenting during EVT was associated with better functional outcomes, and this association was not modified by prior treatment with IVT.
- 1 January 2026
- Published by Wolters Kluwer Health in Stroke
- Vol. 57 (1) , 27-37
Acute Carotid Stenting for Tandem Lesions in Patients Randomized to Endovascular Treatment With or Without Thrombolysis: Results From the IRIS Individual Participant Data Meta-Analysis
BACKGROUND: Equipoise persists whether patients with stroke with carotid tandem lesions undergoing endovascular treatment (EVT) should undergo acute carotid stenting, and whether intravenous thrombolysis (IVT) before EVT should influence this decision. We assessed functional and safety outcomes of acute carotid stenting in patients with carotid tandem lesions randomized to IVT plus EVT or EVT alone. METHODS: Individual participant data meta-analysis of 6 randomized clinical trials conducted in Asia, Europe, and Oceania between 2017 and 2021 investigating IVT plus EVT versus EVT alone in patients with carotid tandem lesions presenting directly to EVT-capable centers. The primary outcome was the 90-day modified Rankin Scale score, assessed with mixed-effect ordinal regression models. Safety outcomes were any intracranial hemorrhage and symptomatic intracranial hemorrhage. A secondary analysis used inverse probability of treatment weighting. Treatment effect heterogeneity between IVT plus EVT and EVT alone was assessed in a 2-step meta-analysis. RESULTS: Overall, 340 of 2267 (15%) patients had carotid tandem lesions with 113 of 329 (34%) undergoing acute carotid stenting. Stenting was associated with better 90-day functional outcomes (adjusted common odds ratio, 1.60 [95% CI, 1.03–2.47]), confirmed in inverse probability of treatment weighting analysis (adjusted common odds ratio, 1.66 [95% CI, 1.08–2.54]). Patients undergoing stenting had no statistically significant higher rates of any intracranial hemorrhage (44% versus 35%; adjusted odds ratio, 1.30 [95% CI, 0.79–2.15]) and symptomatic intracranial hemorrhage (6.3% versus 3.7%; adjusted odds ratio, 2.09 [95% CI, 0.78–5.59]). No heterogeneity in treatment effect was observed in patients randomized to IVT plus EVT (adjusted common odds ratio, 2.07 [95% CI, 1.06–4.07]) or EVT alone (1.21 [95% CI, 0.59–2.50]; P interaction=0.81). CONCLUSIONS: In this international individual participant data meta-analysis of patients with carotid tandem lesions randomized to EVT alone or IVT followed by EVT, acute carotid stenting during EVT was associated with better functional outcomes, and this association was not modified by prior treatment with IVT.
- 6 September 2025
- Published by SAGE Publications in International Journal of Stroke
- Vol. 21 (2) , 212-220
Associations between systolic blood pressure and infarct growth after thrombectomy for acute stroke: A retrospective observational study
Background: The optimal blood pressure control strategy after mechanical thrombectomy (MT) is not well understood, especially for patients with successful recanalization. We hypothesized that low systolic blood pressure (SBP) after MT is associated with infarct growth (IG), even in patients with successful recanalization. Aims: The aim of the present study was to clarify the relationships between IG and SBP parameters in patients treated with MT. Method: Consecutive acute stroke patients who underwent emergent MT from September 2014 through December 2019 were retrospectively enrolled. Diffusion-weighted imaging (DWI) was performed on admission and approximately 24 h after the procedure. IG was calculated as the difference between infarct volume on 24-h DWI and initial DWI. SBP from recanalization to 24-h DWI was used. The associations between IG and SBP parameters, including maximum, minimum, and mean SBPs and coefficient of variation (CV) of SBPs, were evaluated with multiple regression analyses. Results: A total of 377 MT cases (225 male (60%), median age = 76 (interquartile range (IQR) = 68–83) years, median National Institutes of Health Stroke Scale (NIHSS) score = 17 (10–23), median onset to initial DWI time = 131 (79–350) min) were enrolled in this study. Successful recanalization modified the association between SBP parameters and IG (p for interaction < 0.05). In cases with successful recanalization (n = 314), SBP was recorded 7007 times between recanalization and 24-h follow-up magnetic resonance imaging (MRI). Minimum SBP from recanalization to 24-h DWI (standardized coefficient = −0.144, 95% confidence interval (CI) −0.269 to −0.019, p = 0.024, i.e. low minimum SBP was associated with higher IG) and CV of SBP (0.122, 0.003 to 0.241, p = 0.045) were independently associated with IG, even after adjusting for various factors including age, sex, initial NIHSS score, baseline infarct volume, and symptomatic intracerebral hemorrhage. Conclusion: Minimum SBP and CV of SBP after recanalization were associated with IG in consecutive acute stroke patients who underwent successful MT. IG is a sensitive imaging marker for evaluating the effect of post-procedural SBP, and extremely low SBP after MT should be avoided to mitigate IG.
- 6 September 2025
- Published by SAGE Publications in International Journal of Stroke
- Vol. 21 (2) , 212-220
Associations between systolic blood pressure and infarct growth after thrombectomy for acute stroke: A retrospective observational study
Background: The optimal blood pressure control strategy after mechanical thrombectomy (MT) is not well understood, especially for patients with successful recanalization. We hypothesized that low systolic blood pressure (SBP) after MT is associated with infarct growth (IG), even in patients with successful recanalization. Aims: The aim of the present study was to clarify the relationships between IG and SBP parameters in patients treated with MT. Method: Consecutive acute stroke patients who underwent emergent MT from September 2014 through December 2019 were retrospectively enrolled. Diffusion-weighted imaging (DWI) was performed on admission and approximately 24 h after the procedure. IG was calculated as the difference between infarct volume on 24-h DWI and initial DWI. SBP from recanalization to 24-h DWI was used. The associations between IG and SBP parameters, including maximum, minimum, and mean SBPs and coefficient of variation (CV) of SBPs, were evaluated with multiple regression analyses. Results: A total of 377 MT cases (225 male (60%), median age = 76 (interquartile range (IQR) = 68–83) years, median National Institutes of Health Stroke Scale (NIHSS) score = 17 (10–23), median onset to initial DWI time = 131 (79–350) min) were enrolled in this study. Successful recanalization modified the association between SBP parameters and IG (p for interaction < 0.05). In cases with successful recanalization (n = 314), SBP was recorded 7007 times between recanalization and 24-h follow-up magnetic resonance imaging (MRI). Minimum SBP from recanalization to 24-h DWI (standardized coefficient = −0.144, 95% confidence interval (CI) −0.269 to −0.019, p = 0.024, i.e. low minimum SBP was associated with higher IG) and CV of SBP (0.122, 0.003 to 0.241, p = 0.045) were independently associated with IG, even after adjusting for various factors including age, sex, initial NIHSS score, baseline infarct volume, and symptomatic intracerebral hemorrhage. Conclusion: Minimum SBP and CV of SBP after recanalization were associated with IG in consecutive acute stroke patients who underwent successful MT. IG is a sensitive imaging marker for evaluating the effect of post-procedural SBP, and extremely low SBP after MT should be avoided to mitigate IG.
- Open Access
- 20 June 2025
- Published by Medical Association of Nippon Medical School in Journal of Nippon Medical School
- Vol. 92 (3) , 248-252
Food Preference in Parkinson's Disease
Background: Several studies have reported that persons with Parkinson's disease (PD) exhibit a preference for sweet foods. However, because many people favor such foods, this study investigated whether the preference for sweet foods was stronger among patients with PD than among those without PD. Methods: We analyzed 150 patients treated in the neurology department of Nippon Medical School Hospital between July 2021 and November 2021. Forty-nine (33%) had PD and 101 patients (control group) did not. Participants were asked to rate three sweet foods, three salty foods, and three bitter foods (total, nine foods) on a questionnaire where a score of 3 indicated "like", 2 indicated "neutral", and 1 indicated "dislike". The score for each taste preference was defined as the sum of the scores for the three foods representing each taste. Differences in baseline characteristics and taste preference scores between patients with and without PD were then statistically analyzed. Results: The PD group was significantly older than the control group. The PD group obtained a significantly higher sweetness score than the control group (8 [6-9] vs. 7 [3-9], p<0.01). There was no difference in scores for either saltiness (7 [3-9] vs. 7 [3-9], p=0.49) or bitterness (7 [4-9] vs. 7 [3-9], p=0.25). The sweetness score was not significantly correlated with L-dopa dose, L-dopa equivalent dose, or PD disease duration. Conclusion: Patients with PD were more likely than those without PD to prefer sweet foods. These results are important new information on the taste preferences of persons with Parkinson's disease.
- 20 June 2025
- Published by Medical Association of Nippon Medical School in Journal of Nippon Medical School
- Vol. 92 (3) , 248-252
Open AccessFood Preference in Parkinson's Disease
Background: Several studies have reported that persons with Parkinson's disease (PD) exhibit a preference for sweet foods. However, because many people favor such foods, this study investigated whether the preference for sweet foods was stronger among patients with PD than among those without PD. Methods: We analyzed 150 patients treated in the neurology department of Nippon Medical School Hospital between July 2021 and November 2021. Forty-nine (33%) had PD and 101 patients (control group) did not. Participants were asked to rate three sweet foods, three salty foods, and three bitter foods (total, nine foods) on a questionnaire where a score of 3 indicated "like", 2 indicated "neutral", and 1 indicated "dislike". The score for each taste preference was defined as the sum of the scores for the three foods representing each taste. Differences in baseline characteristics and taste preference scores between patients with and without PD were then statistically analyzed. Results: The PD group was significantly older than the control group. The PD group obtained a significantly higher sweetness score than the control group (8 [6-9] vs. 7 [3-9], p<0.01). There was no difference in scores for either saltiness (7 [3-9] vs. 7 [3-9], p=0.49) or bitterness (7 [4-9] vs. 7 [3-9], p=0.25). The sweetness score was not significantly correlated with L-dopa dose, L-dopa equivalent dose, or PD disease duration. Conclusion: Patients with PD were more likely than those without PD to prefer sweet foods. These results are important new information on the taste preferences of persons with Parkinson's disease.
- Open Access
- 1 April 2025
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 64 (7) , 1097-1100
Anti-N-methyl-d-aspartate Receptor Encephalitis Caused by a Teratoma Arising From the Retroperitoneum
Anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis is an autoimmune encephalitis, and 46% of women with anti-NMDAR encephalitis have tumors, of which 94% are ovarian teratomas. Patients with anti-NMDAR encephalitis rarely have extra-ovarian teratomas, particularly extra-ovarian mature cystic teratomas arising from the retroperitoneum. We herein report a 27-year-old woman who was diagnosed with anti-NMDAR encephalitis caused by a teratoma arising from the retroperitoneum. In patients with anti-NMDAR encephalitis, it is important to perform a systemic search, including for extra-ovarian teratomas. Plasma exchange significantly improved the patient's clinical symptoms.
- 1 April 2025
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 64 (7) , 1097-1100
Open AccessAnti-N-methyl-d-aspartate Receptor Encephalitis Caused by a Teratoma Arising From the Retroperitoneum
Anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis is an autoimmune encephalitis, and 46% of women with anti-NMDAR encephalitis have tumors, of which 94% are ovarian teratomas. Patients with anti-NMDAR encephalitis rarely have extra-ovarian teratomas, particularly extra-ovarian mature cystic teratomas arising from the retroperitoneum. We herein report a 27-year-old woman who was diagnosed with anti-NMDAR encephalitis caused by a teratoma arising from the retroperitoneum. In patients with anti-NMDAR encephalitis, it is important to perform a systemic search, including for extra-ovarian teratomas. Plasma exchange significantly improved the patient's clinical symptoms.
- 17 January 2025
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 249, 108748
Cognitive assessment in patients with acute stroke: Exploring early intervention for dementia
- 17 January 2025
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 249, 108748
Cognitive assessment in patients with acute stroke: Exploring early intervention for dementia
- Open Access
- 1 January 2025
- Published by Japan Neurosurgical Society in Neurologia medico-chirurgica
- Vol. 65 (3) , 2024-0196-159
Randomized Clinical Trial of Extending the Time Window of Endovascular Therapy in the Triage of Late Presenting Stroke Beyond 24 h (SKIP-EXTEND): Rationale and Study Protocol
The therapeutic time window for endovascular therapy in acute stroke patients with large-vessel occlusion was extended to 24 hours from onset. Although a retrospective study showed the efficacy of endovascular therapy beyond 24 hours from the last known well, it remains unclear whether endovascular therapy is effective. Extending the time window of Endovascular therapy in the Triage of Late Presenting Strokes beyond 24 h (SKIP-EXTEND trial) aimed to clarify the efficacy of endovascular therapy compared to the best medical management. This is an investigator-initiated, multicenter, prospective, randomized, open-label, blinded end-point clinical trial. Eligibility criteria included adults and pre-stroke modified Rankin scale score ≤2 with internal carotid artery or M1 (horizontal or sphenoidal segment) occlusion beyond 24 to 72 hours of the last known well. The target enrollment is 260 patients, with 130 reeiving endovascular therapy and 130 receiving the best medical treatment. The primary outcome is the rate of favorable outcome defined as a modified Rankin scale score ≤2 at 90 days. The secondary outcomes are the ordinal logistic regression analysis of the modified Rankin scale score and the rate of recanalization at 48 hours. As safety outcomes, the rate of any and symptomatic intracranial hemorrhage at 24 hours and the rate of mortality at 90 days are assessed. This is the first randomized controlled trial to focus on the efficacy of endovascular therapy beyond 24 hours. Our results will not only benefit patients but also reduce healthcare costs. We believe that this novel study will be useful in clinical practice.
- 1 January 2025
- Published by Japan Neurosurgical Society in Neurologia medico-chirurgica
- Vol. 65 (3) , 2024-0196-159
Open AccessRandomized Clinical Trial of Extending the Time Window of Endovascular Therapy in the Triage of Late Presenting Stroke Beyond 24 h (SKIP-EXTEND): Rationale and Study Protocol
The therapeutic time window for endovascular therapy in acute stroke patients with large-vessel occlusion was extended to 24 hours from onset. Although a retrospective study showed the efficacy of endovascular therapy beyond 24 hours from the last known well, it remains unclear whether endovascular therapy is effective. Extending the time window of Endovascular therapy in the Triage of Late Presenting Strokes beyond 24 h (SKIP-EXTEND trial) aimed to clarify the efficacy of endovascular therapy compared to the best medical management. This is an investigator-initiated, multicenter, prospective, randomized, open-label, blinded end-point clinical trial. Eligibility criteria included adults and pre-stroke modified Rankin scale score ≤2 with internal carotid artery or M1 (horizontal or sphenoidal segment) occlusion beyond 24 to 72 hours of the last known well. The target enrollment is 260 patients, with 130 reeiving endovascular therapy and 130 receiving the best medical treatment. The primary outcome is the rate of favorable outcome defined as a modified Rankin scale score ≤2 at 90 days. The secondary outcomes are the ordinal logistic regression analysis of the modified Rankin scale score and the rate of recanalization at 48 hours. As safety outcomes, the rate of any and symptomatic intracranial hemorrhage at 24 hours and the rate of mortality at 90 days are assessed. This is the first randomized controlled trial to focus on the efficacy of endovascular therapy beyond 24 hours. Our results will not only benefit patients but also reduce healthcare costs. We believe that this novel study will be useful in clinical practice.
- 17 August 2024
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 33 (11) , 107943
High plasma BNP concentration associates with clinical outcome after mechanical thrombectomy: Post hoc analysis of SKIP
- 17 August 2024
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 33 (11) , 107943
High plasma BNP concentration associates with clinical outcome after mechanical thrombectomy: Post hoc analysis of SKIP
- Open Access
- 3 June 2024
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 15, 1393345
The randomized study of enteral nutrition with rapid versus conventional administration in acute stroke patients; the protocol of rapid EN trial
Rationale: Enteral nutrition is beneficial for stroke patients with oral intake difficulties. However, it is time consuming and may interfere with routine medical care. Therefore, there is a clinical benefit if enteral nutrition can be safely administered in a short time. Although our retrospective study showed the safety of rapid administration, it remains unclear whether rapid administration of enteral nutrition is as safe as conventional administration.Aim: The randomized study of Enteral Nutrition with Rapid versus conventional administration in acute stroke patients (Rapid EN trial) aims to clarify the safety of rapid feeding of enteral nutrition compared with conventional feeding.Methods and design: This is an investigator-initiated, multicenter, prospective, randomized, open-label, blinded end-point clinical trial. Eligible criteria include acute stroke patients who have difficulty with oral intake defined as severe altered consciousness (Japan Coma Scale 10–300) or modified water swallowing test <4. The target enrollment is 700 patients, with 350 patients receiving rapid enteral nutrition at a rate of 100 mL in 5 min (Rapid EN group) and 350 patients receiving conventional enteral nutrition at a rate of 100 mL in 30 min (Conventional EN group).Study outcome: The primary outcome is the incidence of one or more complications of vomiting or diarrhea or pneumonia within 7 days would be non-inferior in the rapid EN group compared to the conventional EN group. Secondary outcomes were total time spent on enteral nutrition within 7 days from enteral nutrition, the incidence of vomiting, diarrhea and pneumonia within 3 or 7 days, and the rate of favorable clinical outcome.Discussion: Since no previous reports have focused on the speed of administration, we felt it was necessary to prove the safety of rapid administration. If this study shows positive results, it will not only benefit patients, but also reduce the burden of medical care. We believe this study is novel and will be useful in clinical practice.Clinical trial registration: https://rctportal.niph.go.jp/s/detail/um?trial_id=UMIN000046610 Identifier UMIN000046610.
- 3 June 2024
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 15, 1393345
Open AccessThe randomized study of enteral nutrition with rapid versus conventional administration in acute stroke patients; the protocol of rapid EN trial
Rationale: Enteral nutrition is beneficial for stroke patients with oral intake difficulties. However, it is time consuming and may interfere with routine medical care. Therefore, there is a clinical benefit if enteral nutrition can be safely administered in a short time. Although our retrospective study showed the safety of rapid administration, it remains unclear whether rapid administration of enteral nutrition is as safe as conventional administration.Aim: The randomized study of Enteral Nutrition with Rapid versus conventional administration in acute stroke patients (Rapid EN trial) aims to clarify the safety of rapid feeding of enteral nutrition compared with conventional feeding.Methods and design: This is an investigator-initiated, multicenter, prospective, randomized, open-label, blinded end-point clinical trial. Eligible criteria include acute stroke patients who have difficulty with oral intake defined as severe altered consciousness (Japan Coma Scale 10–300) or modified water swallowing test <4. The target enrollment is 700 patients, with 350 patients receiving rapid enteral nutrition at a rate of 100 mL in 5 min (Rapid EN group) and 350 patients receiving conventional enteral nutrition at a rate of 100 mL in 30 min (Conventional EN group).Study outcome: The primary outcome is the incidence of one or more complications of vomiting or diarrhea or pneumonia within 7 days would be non-inferior in the rapid EN group compared to the conventional EN group. Secondary outcomes were total time spent on enteral nutrition within 7 days from enteral nutrition, the incidence of vomiting, diarrhea and pneumonia within 3 or 7 days, and the rate of favorable clinical outcome.Discussion: Since no previous reports have focused on the speed of administration, we felt it was necessary to prove the safety of rapid administration. If this study shows positive results, it will not only benefit patients, but also reduce the burden of medical care. We believe this study is novel and will be useful in clinical practice.Clinical trial registration: https://rctportal.niph.go.jp/s/detail/um?trial_id=UMIN000046610 Identifier UMIN000046610.